Trial
NCT02605863
Enzalutamide for Bladder Cancer Chemoprevention
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Rochester
Collaborators
Astellas Pharma Inc
Condition
Bladder Cancer
Intervention
Enzalutamide
Why stopped
Low enrollment, sponsor withdrew support for study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-03